Murli Krishna Pharma Private Limited, a active private limited company, was established on 02 April 2004 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230PN2004PTC206917. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹32.50 Cr and a paid-up capital of ₹5.39 Cr.
It upholds a compliant status. Employing 218 professional, Its leadership includes Nithyagovind (Nominee Director), Satya Ramani Vadlamani (Managing Director), Venkat Murli Krishna Vadlamani (Director). Past directors included Sau Chun Fung, Nithyagovind, Eshwar Rao Vadlamani. It holds ₹81.68 Cr open charges and ₹13.76 Cr settled loans. Its latest AGM occurred on 03 December 2024, with the balance sheet filed on 31 March 2024. It is based at D-98, Ranjangaon Midc, Tal Shirur,, Pune, Maharashtra, 412209.
U24230PN2004PTC206917
206917
02 April 2004
₹32.50 Cr
₹5.39 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Murli Krishna Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nithyagovind | Nominee Director | 27 May 2020 | Current |
| Satya Ramani Vadlamani | Managing Director | 02 Apr 2004 | Current |
| Venkat Murli Krishna Vadlamani | Director | 15 Jul 2024 | Current |
| Vijay Shastri Kalyanasundaram | Director | 02 Apr 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Aug 2018 | Past |
| Pramod Abcsdd | Additional Director | 28 May 2020 | Past |
| Pramod Abcsdd | Director | 02 Mar 2013 | Past |
| Pramod Abcsdd | Director | 16 Apr 2015 | Past |
| Pramod Abcsdd | Director | 01 Apr 2006 | Past |
| Pramod Abcsdd | Director | 26 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Murli Krishna Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Murli Krishna Pharma had a promoter holding of 19.60% and a public holding of 80.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹816,844,998.00
₹137,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2024 | Others | ₹10.00 Cr | Open |
| 28 Jun 2024 | Others | ₹10.00 Cr | Open |
| 04 Sep 2023 | Axis Bank Limited | ₹1.30 Cr | Open |
| 09 May 2023 | Hdfc Bank Limited | ₹2.30 M | Open |
| 25 Jan 2021 | Hdfc Bank Limited | ₹7.28 M | Open |
Explore comprehensive loan charge details -
Murli Krishna Pharma has a workforce of 218 employees as of Nov 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Murli Krishna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Murli Krishna Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Murli Krishna Pharma Private Limited last Annual general meeting of members was held on 03 Dec 2024 as per latest MCA records. was completed.
Venkat Murli Krishna Vadlamani was appointed as a Director was appointed as a Director on 15 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100950346 was registered on 28 Jun 2024. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100950333 was registered on 28 Jun 2024. was completed.
The activity Murli Krishna Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 59.43 Cr registered on 25 Nov 2020 with Charge ID 100403600 was modified on 01 Feb 2024. was documented.
Shanghai China July 4 Murli Krishna Pharma a leading player in the pharmaceutical manufacturing sector proudly announces its participation in the renowned CPHI China event at the Shanghai New International Expo Center As an esteemed participant Murli Krishna Pharma showcased its expertise and demonstrated its commitment to the global pharma ingredients industry.
The CIN of Murli Krishna Pharma Private Limited is U24230PN2004PTC206917.
Murli Krishna Pharma Private Limited is headquartered at D-98, Ranjangaon Midc, Tal Shirur,, Pune, Maharashtra, 412209.
Murli Krishna Pharma Private Limited was incorporated on 02 April 2004.
The current directors of Murli Krishna Pharma Private Limited are
The primary industry of Murli Krishna Pharma Private Limited is Manufacturing.
Murli Krishna Pharma Private Limited is unlisted.
The authorized capital of Murli Krishna Pharma Private Limited is ₹32.50 Cr, and the paid-up capital is ₹5.39 Cr.
The compliance status of Murli Krishna Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX